Transient Ischemic Attack- LIFT trial

NLength of TreatmentPlaceboTreatmentRR95% CInotes
PlaceboTiboloneNo.RateNo.Rate
TIA2257224934 months0.20%NR0.30%NRNRNRReported as rare

From: Appendix D, Evidence Tables

Cover of Comparative Effectiveness of Medications To Reduce Risk of Primary Breast Cancer in Women
Comparative Effectiveness of Medications To Reduce Risk of Primary Breast Cancer in Women [Internet].
AHRQ Comparative Effectiveness Reviews, No. 17.
Nelson HD, Fu R, Humphrey L, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.